Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
41 studies found for:    " April 16, 2008":" May 16, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP
Condition: HIV Infections
Intervention: Drug: AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP
2 Completed HIV Vertical Transmission in Vietnam
Condition: HIV Infections
Intervention:
3 Completed Qualitative and Quantitative HIV RNA Detection in Saliva Using the Oragene RNA Kit
Condition: HIV Infections
Intervention:
4 Completed
Has Results
Qualitative Assessment of Implementing Routine Rapid HIV Testing
Condition: HIV Infections
Intervention:
5 Completed Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Darunavir;   Drug: Ritonavir;   Drug: Tenofovir/Emtricitabine
6 Completed Enhancing Communication and HIV Outcomes
Condition: HIV Infections
Intervention: Behavioral: communication training
7 Completed Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)
Condition: HIV Infections
Intervention: Drug: Lopinavir/ritonavir
8 Terminated Kaletra and Viread in Antiretroviral Naïve Patients
Condition: HIV Infections
Intervention: Drug: Lopinavir/ritonavir and tenofovir
9 Completed Preventing HIV/Aids in Drug Abusing Youth
Condition: HIV Infections
Interventions: Behavioral: IBFT /HIV prevention;   Behavioral: IBFT
10 Completed Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Emtricitabine/tenofovir disoproxil fumarate
11 Completed An Open Label Treatment Protocol to Provide Continued Elvucitabine Treatment
Condition: HIV Infections
Intervention: Drug: elvucitabine
12 Unknown  Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda
Condition: HIV Infections
Interventions: Drug: cotrimoxazole;   Drug: Placebo
13 Completed Phase II Study of AGS‑004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV
Condition: HIV Infections
Intervention: Biological: AGS-004
14 Suspended Bioequivalence Study of Didanosine in Children Treated for HIV
Condition: HIV Infections
Intervention: Drug: didanosine
15 Completed Pilot Trial of a Synbiotic in HIV+ Patients
Condition: HIV Infection
Interventions: Dietary Supplement: Synbiotic 2000;   Dietary Supplement: Placebo
16 Completed Impact of Peer Health Workers and Mobile Phones on HIV Care
Condition: HIV Infections
Interventions: Behavioral: Peer Health Workers Intervention;   Behavioral: Peer Health Workers and Mobile Phone Intervention
17 Completed Rapid HIV Testing for Emergency Department Patients
Condition: HIV Infections
Intervention: Behavioral: HIV risk education
18 Completed
Has Results
Raltegravir Augmentation on Persistent Central Nervous System (CNS) Immunoactivation in Treated HIV-1 Patients
Condition: HIV Infections
Intervention: Drug: raltegravir
19 Completed Raltegravir as Early Therapy in African-Americans Living With HIV Study
Condition: HIV Infections
Intervention: Drug: Raltegravir + Truvada
20 Completed Study of Provider Computer Alerts Designed to Improve Delivery of HIV Care
Condition: HIV Infections
Interventions: Other: Standard (static) Computer Alerts;   Other: Enhanced Computer Alerts

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.